Vitamin D and COVID-19: What Doctors Know (and Don't Know)

New Post Public Reply Private Reply Replies (1) Message Board
toodles
380
Vitamin D and COVID-19: What Doctors Know (and Don't Know) So Far
Research continues into whether supplements can prevent or treat coronavirus infections

In the early days of the pandemic, when health care workers were struggling to treat patients who poured into emergency rooms sick with COVID-19, a 2017 study landed in David Meltzer's inbox that gave him an idea. It found that people who took vitamin D were less likely to have a viral respiratory tract infection.

"At that point, we had nothing” to treat COVID-19, says Meltzer, M.D., chief of the Section of Hospital Medicine at the University of Chicago. “We didn't have dexamethasone [a steroid now used to help counter inflammation caused by a coronavirus infection] — we truly had nothing. So I thought, Wow, this is worth looking into.”

In the last year, Meltzer has published two studies exploring vitamin D and its potential impact on COVID-19 risk — and he's not the only one. Several others have investigated vitamin D as a tool for COVID-19 prevention or treatment, and around 50 studies on the subject are currently active or recruiting participants, according to the government's registry of clinical trials.

Why is there such interest in vitamin D?
There are a few reasons researchers have zeroed in on vitamin D, which is perhaps best known for its bone-health benefits. For starters, it plays an important role in immune function and helps keep inflammation in check. And “one of the problems” with COVID-19, Meltzer says, is that some people's immune systems go into overdrive, “and you get inflammation in the lungs and shortness of breath, and all that sort of stuff.”

Plus, vitamin D deficiency is relatively common, especially among certain populations, including people with dark skin, older adults, individuals who are homebound or in nursing homes, and obese people — all groups that have been hit hard by the coronavirus.

Another reason for the interest: “In reasonable doses,” vitamin D is safe for most people, explains Robert Shmerling, M.D., senior editor at Harvard Health Publishing and corresponding faculty at Harvard Medical School. Plus it's pretty easy to find. Vitamin D is naturally present in some foods, including salmon and cheese. It can also be obtained through sunlight and supplements.

Where to get vitamin D
Sunlight: 5 to 30 minutes of sun exposure at least twice a week
Supplements (600 to 800 international units a day)
Fatty fish such as trout, salmon, tuna and mackerel
Cheese
Egg yolks
Mushrooms
Fortified foods, including cereal, milk and orange juice
Source: NIH

The recommended daily amount of vitamin D is at least 600 international units (IUs) for people ages 19 to 70 and at least 800 IUs for those older than 70, according to the National Institutes of Health (NIH). It's important to keep in mind that too much vitamin D can cause serious health complications. The NIH sets the tolerable upper intake for adults at 4,000 IUs per day.

What does the science say so far about vitamin D?
Several studies have shown an association between low vitamin D levels and increased risk for COVID-19, though not a direct link. A paper published in September 2020 from Meltzer and his colleagues found that people who were vitamin D-deficient were more likely to test positive for COVID-19. A more recent study from Meltzer noted that Black individuals who have higher levels of vitamin D were less likely to test positive for COVID-19 than people with sufficient levels.

Researchers in Spain reported in August 2020 that a form of vitamin D called calcifediol reduced intensive care admissions among patients with COVID-19. However, a 2020 study conducted in Brazil concluded that a single high dose of vitamin D did not affect disease severity.

a a r p membership card
Save 25% when you join AARP and enroll in Automatic Renewal for first year. Get instant access to discounts, programs, services, and the information you need to benefit every area of your life.

Shmerling's advice? “Stand by.” There's not enough scientific evidence right now to prove that vitamin D is helpful in preventing or treating COVID-19, but it's possible we'll get data out of the 50-some ongoing studies “and learn more about who really benefits from extra vitamin D and who doesn't,” he adds.
In the meantime, both experts say there's no downside to taking a supplement or multivitamin that contains the recommended amount of vitamin D — especially if you're concerned you don't get enough through your diet or sunlight. But it's always a good idea to consult a doctor first, especially if you are on other medications.

"There's a lot we don't understand about the biology of this,” Meltzer says. “But in the absence of that, there are some very safe things we can do, like take low-level daily vitamin D supplements and get some sun.”

Meltzer is also a proponent of study participation, and he's currently enrolling adults, including those who have been vaccinated, for two randomized controlled trials to test whether vitamin D supplements can reduce the risk and severity of COVID-19.

What has been proven to prevent and treat COVID?
So far only one drug, remdesivir, has been approved by the Food and Drug Administration (FDA) for the treatment of COVID-19, and several monoclonal antibodies have been authorized under emergency use. Health care providers may also administer other therapies, including antiviral medications, blood thinners and steroids, to help minimize damage from the virus in hospitalized patients.

When it comes to illness prevention, three vaccines — from Moderna, Pfizer-BioNTech and Johnson & Johnson — have cleared FDA authorization. And the Centers for Disease Control and Prevention (CDC) recommends everyday efforts, such as wearing a mask in public and avoiding crowds, to help keep people from getting sick. Experts also stress the importance of a healthy diet for disease prevention, since chronic health conditions associated with poor nutrition and lack of physical activity increase a person's risk for more severe outcomes from a coronavirus infection.

Beyond Vitamin D: What About Zinc, Vitamin C, Melatonin and Pepcid?
While vitamin D is the most studied supplement surrounding COVID-19, it isn't the only one. Researchers are also looking into whether vitamin C (an antioxidant with anti-inflammatory properties) and zinc (a mineral also important in immune health) hold any power over the coronavirus. For example, one registered trial will look at the impact intravenous vitamin C has on COVID-19 disease severity; another will study whether combination therapies —


TOODLES

1
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Faces Class Action Deadline Over Fraud Claims

Updated Category News Views 74

Gildan's Legal Storm: Fraud Allegations When news hits about a big player like Gildan Activewear (NYSE: GIL) facing a class-action lawsuit, it's like a thunderstorm for investors who traded their stocks between February 19, 2025, and June 15, 2026. This lawsuit alleges what we some might call classic financial engineering—channel stuffing to be precise—that’s got...

Continue Reading
Why Accurate HVAC Load Calculations Matter

Updated Category News Views 205

Beyond Square Footage: Critical HVAC Considerations When it comes to heating and cooling your home, simply considering its square footage is like trying to predict the weather with nothing but a coin flip. Bob Schmid, an HVAC guru from Ocean View, NJ, pulls back the curtain on why the details really matter in determining the most efficient and effective HVAC setup for any...

Continue Reading
Context Labs Unveils AI Distillery for Enterprises

Updated Category News Views 517

Rethinking AI with Sovereignty in Mind A bouquet of tech buzzwords lands on every investor's doorstep with the unveiling of Context Labs' latest contraption. We’re talking about the AI Distillery™, which promises enterprises a way to run sovereign AI systems by keeping data in-house. Now, if you’re nodding along to the buzz, let's cut through the clutter....

Continue Reading
Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Updated Category News Views 197

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

Continue Reading
Baystate Health Expands: A New Chapter with Mercy

Updated Category News Views 121

Baystate Health Moves Forward with Strategic Integration Well, here's a tale that's as much about legacy as it is about progress. Baystate Health has brought Baystate Mercy Hospital into its fold, blending history with future prospects. This integration, folks, isn't just a merger—it's a downright overhaul of how healthcare operates in Western Massachusetts. We’re...

Continue Reading
Home Genius Exteriors Expands with Five New Locations

Updated Category News Views 125

Pushing Beyond the Backyard: Home Genius Opens New Doors Hold onto your hats, folks. Home Genius Exteriors is making a splashy move by setting up shop in five new points across the map. We're talking Toledo, Ohio; Nashville, Tennessee; Lehigh Valley and Erie in Pennsylvania; and Dover, Delaware. That's quite a leap from their cozy base of operations, marking a clear push...

Continue Reading
Bahrain's USD 3.89 Billion Investment Surge in 2026

Updated Category News Views 187

Bahrain's Bold Moves to Woo Global Investment Bahrain's never been one to tiptoe around, huh? With a whopping USD 3.89 billion on the line, the Kingdom's flashing its neon sign to investors: "Open for Business!" These Golden License projects aren't just a few shiny new ventures — they're bridging aviation logistics, real estate, and the tech sector. Talk about ambition....

Continue Reading
Decoding Real Estate Value: A Market Insider's Take

Updated Category News Views 270

Riding the Waves of Real Estate Pricing Homeowners dipping their toes into the real estate market know that setting the right price ain't a walk in the park. Luckily, Matt Nuzie, Shelton's real estate pro, has peeled back the layers on comparative market analyses (CMA) in a HelloNation piece. This isn't just about tossing a number out there—it's about understanding the...

Continue Reading
Ensuring Flooring Stability: Acclimation's Key Role

Updated Category News Views 191

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Continue Reading
XPeng Hits New Monthly Delivery Record in October

Updated Category News Views 247

XPeng Smashes Delivery Records Yet Again Ah, the green light’s on for XPeng, and it's a bright one! This October, we learned that XPeng hit the throttle hard with a new record of 50,237 vehicles delivered. Now, that's a sizable rally—a 22% climb month-over-month and shooting 20% higher than last October. For a company like XPeng, which resembles a bulldog with its...

Continue Reading

Top 5 Most Recently Viewed Articles

Medicenna's MDNA11 Progress and Insights from ABILITY-1 Study

Updated Category News Views 124

Overview of Medicenna Therapeutics Medicenna Therapeutics Corp. is a dynamic player in the clinical-stage immunotherapy arena, particularly noted for their innovative developments centered around Superkines. Their focus on creating next-generation therapeutic options has positioned them as a notable entity in the fight against cancer. Recently, the company announced the...

Continue Reading
Important Class Action Update for PACS Group Investors

Updated Category News Views 266

Key Information for PACS Group Investors Faruqi & Faruqi, LLP is actively reaching out to investors impacted by their investment in PACS Group. If you've faced losses exceeding $50,000, it's crucial to consider your legal options. The firm is encouraging investors to connect with Josh Wilson, a partner at the firm, for clarification of rights and options. PACS Group is...

Continue Reading
Stock Market Fluctuations: Key Players and Recent Performances

Updated Category News Views 134

Market Updates and Performance Overview The U.S. stock market showcased a mix of performances as trading commenced recently. The Dow Jones index experienced a slight decline of approximately 0.1% amidst varying trends across other indices. Sector Analysis As trading opened, the Dow was recorded at 48,698.11, reflecting a 0.07% drop, whereas the NASDAQ showed signs of...

Continue Reading
Signal Rock Capital Launches Investment Strategy for Growth

Updated Category News Views 360

Signal Rock Capital Launches New Investment Venture Signal Rock Capital, a new private investment firm, is making waves in the investment world by focusing on lower middle-market businesses. The firm, co-founded by passionate investors, aims to partner with innovative, founder-led companies that operate in often overlooked sectors of the economy. Investment Focus and...

Continue Reading
Microsoft's Dividend Boost and Buyback Strategy Leads to Growth

Updated Category News Views 135

Microsoft's Strategic Financial Moves Recently, Microsoft Corporation (NASDAQ: MSFT) made waves by announcing a significant increase in its quarterly dividend and a new share repurchase program. Following the news, Deutsche Bank reaffirmed its Buy rating on Microsoft’s stock and set a price target of $475. This move to raise the dividend by 10.7%, from $0.75 to $0.83...

Continue Reading